Synapse Open Synapse
Biology

Court rejects Novo bid to block Lilly obesity drug ads

BioPharma Dive · · 2 min read

Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the Danish company’s sales, a federal judge ruled.

Latest from BioPharma Dive